The antibody–drug conjugate anti-CD248-MC-VC-PABC-MMAE, with 3–4 MMAE molecules per ADC, was selectively cytotoxic to CD248-positive cells in culture and produced profound, durable tumor control in human CD248-positive tumor xenografts. Here, CD248 is linked to neoplasm.